Decrease in serum concentrations of Helicobacter pylori IgG antibodies during antituberculosis therapy: the possible eradication by rifampicin and streptomycin.
Sanaka
M
M
Kuyama
Y
Y
Yamanaka
M
M
Iwasaki
M
M
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood*; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology*
D000904:Antibiotics, Antitubercular; D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D012293:Rifampin; D013307:Streptomycin